# Atrial Fibrillation Ablation and Autonomic Modulation Via Thorascopic Surgery

Study · id `cardio:ct-nct01091389` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01091389](<https://clinicaltrials.gov/study/NCT01091389>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01091389

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.

## Technical summary

Registry record NCT01091389. Randomized; single masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2015-02-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 240 participants (enrolled count; ClinicalTrials.gov record NCT01091389, source copy `cardio:ctgov-nct01091389-2017-04-25`, retrieved 2026-11-18)
- Start date: 2010-03 (registry gives no type) (ClinicalTrials.gov record NCT01091389, source copy `cardio:ctgov-nct01091389-2017-04-25`, retrieved 2026-11-18)
- Primary completion: 2015-02-23 (actual) (ClinicalTrials.gov record NCT01091389, source copy `cardio:ctgov-nct01091389-2017-04-25`, retrieved 2026-11-18)
- Completion: 2017-01 (actual) (ClinicalTrials.gov record NCT01091389, source copy `cardio:ctgov-nct01091389-2017-04-25`, retrieved 2026-11-18)
- Countries: Netherlands (ClinicalTrials.gov record NCT01091389, source copy `cardio:ctgov-nct01091389-2017-04-25`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01091389-2017-04-25`, retrieved 2026-11-18)

## The registry's words

- Brief title: Atrial Fibrillation Ablation and Autonomic Modulation Via Thorascopic Surgery
- Acronym: AFACT
- Condition: Atrial Fibrillation
- Intervention (Procedure): Totally Thoracoscopic PV isolation
- Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Lead sponsor class: OTHER
- Collaborator: Netherlands Heart Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (`cardio:org-academisch-medisch-centrum-universiteit-van-amsterdam-amc-662d32`)
- Registry lists this organization as a collaborator: Netherlands Heart Foundation (`cardio:org-netherlands-heart-foundation`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study (`cardio:pubmed-27609676`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation (`cardio:pubmed-32814717`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Does left atrial epicardial conduction time reflect atrial fibrosis and the risk of atrial fibrillation recurrence after thoracoscopic ablation? Post hoc analysis of the AFACT trial (`cardio:pubmed-35264365`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Clinical, histologic, and molecular associations of early and late recurrence after thoracoscopic ablation for atrial fibrillation (`cardio:pubmed-42229869`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 869bf106c905640177f3d25bad86563e5a8a20b6f5a3933a05dfd5d3ccd8f7c8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
